+ All Categories
Home > Documents > Ph hytate-Compplex as a Novel MRI Agent for Tumor ...

Ph hytate-Compplex as a Novel MRI Agent for Tumor ...

Date post: 09-Apr-2022
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
1
Ph 1 Radi INTR Tumor detecti orthoto variant utility MATE Determ isother phytate Biodis Spragu perform Elucid Evalua RAW2 were w Inocul penicil inocula diamet MRI: Germa ms, wi calcula admini = 30×3 RESU Determ saturat data su Biodis biodist h in th (PB) s macrop Elucid contras specifi Evalua shown i.e., 16 Detect hypo-i and pre Doxor has hig were fu DISC Phytate chemic physio therefo direct d and tum REFE [1] Ste Hill R Harisin ACKN This w hytate-Comp iology, Seoul Nat RODUCTION r-associated macrop ion of tumors with opic murine model t by combining the of this novel antitum ERIALS AND M mination of the Th rmal titration microc e solution. To minim stribution of ICPC ue–Dawley (SD) rat med to confirm the dation of ICPC Upt ation of ICPC as 264.7 macrophages washed with PBS, an lation of B16F1 Me llin-streptomycin. B ated 8-week-old C5 ter . MRI scans were MRI studies were any). For the estimat ith a step size of 1.0 ated using Matlab istration of ICPC (n 30 mm 2 ; matrix size ULTS mination of the Th tion in accordance w upport the use of IC stribution of ICPC tribution and retenti e liver and at 8 h in staining (data not s phages, in particula dation of ICPC Up st, residential perito ic. These data strong ation of ICPC as a in Fig. 2d. The ICP 6-fold higher than th tion of Metastatic ntense LN metastas edominantly engulf rubicin-ICPC Com gh affinity for doxo urther confirmed by CUSSION e has long been use cal nature of phytate ological conditions [ ore distinct from tha detection of tumor m mor-specific drug d RENCES eidl C, NEJM 362, 8 P , Science 224, 998 nghani MG, NEJM NOWLEDGEMEN work was supported plex as a Nove tional University phages (TAMs) accu high specificity. He of metastatic melan ICPC with an anti mor MR agent that METHODS hermodynamics of calorimeter (Microc mize the ability of F C and Identification ts. The biodistributi identity of the cells take by Macropha an Effective Mac were cultured in 10 nd ICPC-labeled ce elanoma Mice: B1 B16F1 cells were tr 57BL/6 male mice e then performed for performed on a 9. tion of relaxation ra 0 ms. Other imagin (MathWorks Inc., n=9). A GE and a sp e = 384×384; 15 slic hermodynamics of with a two-site set m PC as an injectable C and Identificati ion time in C57BL/ n the spleen. Other t hown). These resu ar hepatic Kupffer ce ptake by Macropha oneal macrophages gly suggest that ICP an Effective Macr PC alone had an est hat of ICPC alone (F Lymph Nodes in B sis is clearly detect fed by F4/80 + macro mplex (Dox@ICPC orubicin (22.7 nM). y PB staining. ed for the detection e is ideally suited fo [3]. Activated macro at of iron-oxide nan metastases. Our pre delivery simultaneou 875 (2010). [2] Dald 8 (1984). [6] Sewa 348, 2491 (2003). TS by Korean Ministry el MRI Agent Hospital, Seoul, umulate in various ere, we developed a noma. Beyond the icancer drug. Using achieves both TAM Fe 3+ Binding to Ph cal, USA) [3]. Base Fe 3+ -phytate to chela n of the Cells that ion and retention tim s that absorbed ICPC ages: we used thiogl crophage-specific M 0-cm 2 plates at a de ells were prepared in 6F1 melanoma cell ansfected with an F with 4×10 5 B16F1 r metastatic lymph n .4 T MR scanner w ate (R2*) and relaxi g parameters were: USA). For in vivo pin echo sequence ( ces (0.5 mm); NEX f ICPC: Fig. 1a illu model, in which Fe 3 MRI contrast agent on of the ICPC-A /6 mice are shown i tissues, including th lts support the app ells (Fig. 1e) and sin ages: LPS-stimulat did not ingest ICPC PC is selectively eng rophage-specific M timated r 2 * of 82.9 ± Fig. 2e). B16F1-GFP Melan ed. These findings ophages within tumo ): Fig.3c illustrates In Fig. 3d, fluores of sentinel LNs in or simultaneously b ophages are then ab noparticles, which ca eliminary data also s usly . drup-Link HE, Clin atkar AB, Nucl Med y of Educational Sci t for Tumor A Hyeonjin Seoul, Korea, Re cancers and promo an iron-calcium-phy capability of curren g a Doxorubicin-ICP M-specific MR imag hytate and Prepar ed on our ITC result ate Ca 2+ from the bl Absorbed ICPC: me of ICPC were e C. lycollate-elicited pe MRI Probe: ICPC ensity of 2 × 10 6 ce n PCR tubes. s were cultured in D FG12 lentiviral vect or B16F1-GFP me node (LN) imaging with a transmit-only ivity (r2*) of ICPC TR = 8000 ms; flip o LN imaging in a SE) were used (resp = 8). ustrates the thermod 3+ ions bind one set t, due to its stability Absorbing Cells : n Figs. 1c and 1d, r he brain, heart, lung, plication of ICPC a nusoidal lining cells ed TEPM more eff C. As an additional gulfed by activated MRI Probe: Fig. 2c ± 3.1 mM -1 s -1 . Incub noma Mice In Vivo were confirmed by or regions, as the an the thermodynami scence analysis clea cancer patients in th inding Fe 3+ and Ca 2 ble to engulf these in an also localize to h strongly support tha Cancer Res, 17, 56 d (Stuttg) 14, 46 (1 ience and Technolo Associated M Delivery Kim 1 , and Byung epublic of, 2 Lee G Republic of ote tumor angiogen ytate complex (ICP nt TAM imaging m PC complex (Dox@ ging and tumor-spec ration of ICPC: we ts, a 10 mM solutio lood, equimolar con The clearance of IC examined in C57BL eritoneal macrophag C alone and ICPC-l ells mL -1 in a mediu DMEM complete m tor that expressed g elanoma cells per m g. Regional LNs (lef y volume coil for in vitro, a gradient p angle (FA) = 90º; animals, we perfor piratory-gated and f dynamics of ICPC t of binding sites wi y under physiologic The clearance of respectively. ICPC c , kidney, lymph nod as an MRI agent fo s of the spleen (Fig. ficiently engulfed IC l control, B16F1 me macrophages. c shows the MR im bation of macrophag o: Fig. 3a shows th y GFP fluorescence ntibody staining com ics of Dox@ICPC o arly demonstrated th the form of techneti 2+ ions and even an nsoluble ICPC parti healthy LNs [9]. In s at the novel antitum 695 (2011). [3] Kim 1975). [7] Ege GN, ogy (2010-0024500, Macrophage (T g-Chul Oh 2 Gil Ya Cancer and nesis and progressio PC) as an MRI agen methods, which is lim @ICPC), we also p cific drug delivery si e performed isotherm on of Fe 3+ -phytate w ncentrations of Ca 2+ CPC from blood wa L/6 mice. Immunohi ges (TEPM) from w labeled RAW264.7 um (ICPC concentr medium (Sigma-Aldr green fluorescence p mouse via the left fr ft axillary and brach excitation and a ph echo sequence (GE ; FOV = 60×60 mm rmed MRI scans b fat-suppressed; TR/ obtained by ITC an ith high affinity (4.6 al conditions [3]. ICPC from blood clearance from the b de, and thymus, sho or use in vivo. The . 1f) [6]. CPC in a dose-depe elanoma cells did n mages used for the e ges with various con he pre- and post-co and PB staining (F mpletely overlapped obtained by ITC an hat Dox@ICPC wa ium-phytate (Tc-phy anticancer drug suc icles [8]. The ability summary, we have mor MR agent, Dox@ m OH, Biochemistry , J Nucl Med 19, 1 , 2011-0002622). TAM)-specifi d Diabetes Institu on [1], and thus mi nt that specifically t mited to visualizati resent our prelimin imultaneously. mal titration calorim was prepared by mix ions were added to as investigated after istochemical (IHC) wild-type mice, whic macrophages were ations ranging 0 - 0 rich, USA) with 10% protein (GFP) unde ront footpad [5]. Th hial) and non-region hased array 4-chann ) was used with 8 d m 2 ; matrix size = 25 efore and 4, 8, 16 TE = 335/6.7 ms fo nalyses. Titration of 62 μM) and bind an after i.v. injection blood was rapid. M wed very low level IHC results clearl endent manner, as c ot take up ICPC (F estimation of R2* o ncentrations of ICP ntrast MR images o Fig. 3b). IHC analys d the PB staining (F nalysis. Titration of as selectively targete ytate), an establishe ch as doxorubicin, s y of ICPC to target a developed a tumor- @ICPC, may potent y 49, 10216 (2010). 1362 (1978). [8] Gu ic Image Con ute, Gachon Univ ight be ideal imagin targets TAMs, and ion of TAMs [2], w nary results that stro metry (ITC) experim xing equimolar conc o the Fe 3+ -phytate so r i.v. injection of th ) staining using an a ch represent inflamm e imaged for relax 0.3 mM). After incu % heat-inactivated F er the control of the he tumor was allow nal LNs were harves nnel surface coil for different echo times 56×256; 1 slice (0.5 6, and 24 h after i or GE and 4000/58 m f Fe 3+ into phytate nother set with low n (10 μmolkg -1 ) in Maximal ICPC uptak ls of ICPC uptake, a ly showed that ICP compared to unstim Fig. 2b), confirming of ICPC in vitro. T PC resulted in an r 2 * of the B16F1-GFP sis demonstrated th Fig. 3b). doxorubicin into p ted in tumor regions ed radiopharmaceut subsequently formin activated macropha -specific MRI agent tially achieve both [4] Kuziel WA,2. P udewicz PW, J Ce ntrast and Dr versity, Incheon, K ng targets for non-i validated its efficac we also developed a ongly support the p ments using a Micro centrations of Fe 3+ i olution (pH = 6.0). e agent (10 μmolk antibody against F4 mation-activated cel xation rate (R2*) m ubation for 12 h, th FBS (Gibco, USA) e ubiquitin C promo wed to grow to ~ 1. sted from the mice. r signal reception ( (TEs) ranging 3.14 mm); NEX = 4. R2 ntravenous (10 μm ms for SE), FA = 90 exhibited Fe 3+ bind affinity (31.25 μM) nto SD rats as wel ke in the mice occur as verified by Pruss PC was engulfed b mulated TEPM (Fig g that ICPC is macro The resulting R2* m of 1056.1 ± 105.9 m melanoma mice wh hat ICPC was prefer hytate showed that s of metastatic LNs ical agent for PET ng insoluble particle ages within tumor re t for use in the accur TAM-specific MR i PNAS 94, 12053 (19 ll Biol 87, 427 (19 rug Korea, invasive cy in an an ICPC potential ocal 200 ions and g -1 ) into 4/80 was lls [4]. mapping. he plates and 1% oter. We 0 cm in (Bruker, 4 - 10.14 2* were molkg -1 ) 0º; FOV ding site ). These ll as its rred at 4 ian blue y tissue . 2a). In ophage- maps are mM -1 s -1 , here the rentially phytate s, which [7]. The es under egions is rate and imaging 997). [5] 980). [9] 1637 Proc. Intl. Soc. Mag. Reson. Med. 20 (2012)
Transcript

Ph

1Radi

INTRTumordetectiorthotovariantutility MATEDetermisotherphytateBiodisSpraguperformElucidEvaluaRAW2were wInoculpenicilinoculadiametMRI: Germams, wicalculaadmini= 30×3RESUDetermsaturatdata suBiodisbiodisth in th(PB) smacropElucidcontrasspecifiEvaluashowni.e., 16Detecthypo-iand preDoxorhas higwere fuDISCPhytatechemicphysiotherefodirect dand tumREFE[1] SteHill RHarisinACKNThis w

hytate-Comp

iology, Seoul Nat

RODUCTION r-associated macropion of tumors with opic murine model t by combining the of this novel antitumERIALS AND Mmination of the Thrmal titration microce solution. To minimstribution of ICPCue–Dawley (SD) ratmed to confirm the dation of ICPC Uptation of ICPC as

264.7 macrophages washed with PBS, anlation of B16F1 Mellin-streptomycin. Bated 8-week-old C5ter. MRI scans wereMRI studies were

any). For the estimatith a step size of 1.0ated using Matlab istration of ICPC (n30 mm2; matrix sizeULTS mination of the Thtion in accordance wupport the use of ICstribution of ICPCtribution and retentie liver and at 8 h in

staining (data not sphages, in particula

dation of ICPC Upst, residential peritoic. These data strongation of ICPC as a in Fig. 2d. The ICP

6-fold higher than thtion of Metastatic ntense LN metastasedominantly engulf

rubicin-ICPC Comgh affinity for doxofurther confirmed byCUSSION

e has long been usecal nature of phytate

ological conditions [ore distinct from thadetection of tumor mmor-specific drug dRENCES

eidl C, NEJM 362, 8P, Science 224, 998nghani MG, NEJM

NOWLEDGEMENwork was supported

plex as a Nove

tional University

phages (TAMs) accuhigh specificity. Heof metastatic melan ICPC with an antimor MR agent that

METHODS hermodynamics of calorimeter (Microcmize the ability of F

C and Identificationts. The biodistributiidentity of the cellstake by Macrophaan Effective Macwere cultured in 10nd ICPC-labeled ceelanoma Mice: B1

B16F1 cells were tr57BL/6 male mice e then performed for

performed on a 9.tion of relaxation ra0 ms. Other imagin(MathWorks Inc.,

n=9). A GE and a spe = 384×384; 15 slic

hermodynamics ofwith a two-site set mPC as an injectable

C and Identificatiion time in C57BL/

n the spleen. Other thown). These resu

ar hepatic Kupffer ceptake by Macrophaoneal macrophages gly suggest that ICPan Effective MacrPC alone had an esthat of ICPC alone (FLymph Nodes in Bsis is clearly detectfed by F4/80+ macro

mplex (Dox@ICPCorubicin (22.7 nM).y PB staining.

ed for the detection e is ideally suited fo[3]. Activated macroat of iron-oxide nanmetastases. Our pre

delivery simultaneou

875 (2010). [2] Dald8 (1984). [6] Sewa348, 2491 (2003). TS by Korean Ministry

el MRI Agent

Hospital, Seoul,

umulate in various ere, we developed anoma. Beyond the icancer drug. Usingachieves both TAM

Fe3+ Binding to Phcal, USA) [3]. Base

Fe3+-phytate to chelan of the Cells that ion and retention tims that absorbed ICPCages: we used thioglcrophage-specific M0-cm2 plates at a deells were prepared in6F1 melanoma cellansfected with an Fwith 4×105 B16F1 r metastatic lymph n.4 T MR scanner wate (R2*) and relaxig parameters were:USA). For in vivo

pin echo sequence (ces (0.5 mm); NEX

f ICPC: Fig. 1a illumodel, in which Fe3

MRI contrast agenton of the ICPC-A/6 mice are shown itissues, including thlts support the appells (Fig. 1e) and sinages: LPS-stimulatdid not ingest ICPC

PC is selectively engrophage-specific Mtimated r2

* of 82.9 ±Fig. 2e). B16F1-GFP Melaned. These findings ophages within tumo): Fig.3c illustrates In Fig. 3d, fluores

of sentinel LNs in or simultaneously bophages are then ab

noparticles, which caeliminary data also susly.

drup-Link HE, Clinatkar AB, Nucl Med

y of Educational Sci

t for Tumor A

Hyeonjin Seoul, Korea, Rep

cancers and promoan iron-calcium-phycapability of curren

g a Doxorubicin-ICPM-specific MR imag

hytate and Prepared on our ITC resultate Ca2+ from the blAbsorbed ICPC: me of ICPC were eC. lycollate-elicited peMRI Probe: ICPCensity of 2 × 106 cen PCR tubes. s were cultured in DFG12 lentiviral vector B16F1-GFP menode (LN) imagingwith a transmit-onlyivity (r2*) of ICPC TR = 8000 ms; flip

o LN imaging in aSE) were used (resp= 8).

ustrates the thermod3+ ions bind one set t, due to its stability

Absorbing Cells :n Figs. 1c and 1d, r

he brain, heart, lung,plication of ICPC anusoidal lining cellsed TEPM more effC. As an additional gulfed by activated

MRI Probe: Fig. 2c± 3.1 mM-1s-1. Incub

noma Mice In Vivowere confirmed byor regions, as the an the thermodynami

scence analysis clea

cancer patients in thinding Fe3+ and Ca2

ble to engulf these inan also localize to hstrongly support tha

Cancer Res, 17, 56d (Stuttg) 14, 46 (1

ience and Technolo

Associated MDelivery

Kim1, and Byungepublic of, 2Lee G

Republic of

ote tumor angiogenytate complex (ICPnt TAM imaging mPC complex (Dox@

ging and tumor-spec

ration of ICPC: wets, a 10 mM solutiolood, equimolar conThe clearance of IC

examined in C57BL

eritoneal macrophagC alone and ICPC-lells mL-1 in a mediu

DMEM complete mtor that expressed g

elanoma cells per mg. Regional LNs (lefy volume coil for in vitro, a gradient p angle (FA) = 90º;animals, we perforpiratory-gated and f

dynamics of ICPCt of binding sites wiy under physiologic

The clearance of respectively. ICPC c, kidney, lymph nodas an MRI agent fos of the spleen (Fig.ficiently engulfed ICl control, B16F1 memacrophages.

c shows the MR imbation of macrophag

o: Fig. 3a shows thy GFP fluorescence ntibody staining comics of Dox@ICPC oarly demonstrated th

the form of techneti2+ ions and even an nsoluble ICPC partihealthy LNs [9]. In sat the novel antitum

695 (2011). [3] Kim1975). [7] Ege GN,

ogy (2010-0024500,

Macrophage (T

g-Chul Oh2 Gil Ya Cancer and

nesis and progressioPC) as an MRI agenmethods, which is lim@ICPC), we also pcific drug delivery si

e performed isothermon of Fe3+-phytate wncentrations of Ca2+

CPC from blood waL/6 mice. Immunohi

ges (TEPM) from wlabeled RAW264.7 um (ICPC concentr

medium (Sigma-Aldrgreen fluorescence p

mouse via the left frft axillary and brachexcitation and a phecho sequence (GE; FOV = 60×60 mmrmed MRI scans bfat-suppressed; TR/

obtained by ITC anith high affinity (4.6al conditions [3]. ICPC from blood

clearance from the bde, and thymus, shoor use in vivo. The. 1f) [6]. CPC in a dose-depeelanoma cells did n

mages used for the eges with various con

he pre- and post-coand PB staining (F

mpletely overlappedobtained by ITC anhat Dox@ICPC wa

ium-phytate (Tc-phyanticancer drug suc

icles [8]. The abilitysummary, we have

mor MR agent, Dox@

m OH, Biochemistry, J Nucl Med 19, 1

, 2011-0002622).

TAM)-specifi

d Diabetes Institu

on [1], and thus mint that specifically tmited to visualizatiresent our preliminimultaneously.

mal titration calorimwas prepared by mix

ions were added to as investigated afteristochemical (IHC)

wild-type mice, whicmacrophages were

ations ranging 0 - 0

rich, USA) with 10%protein (GFP) underont footpad [5]. Thhial) and non-regionhased array 4-chann) was used with 8 d

m2; matrix size = 25efore and 4, 8, 16TE = 335/6.7 ms fo

nalyses. Titration of62 μM) and bind an

after i.v. injectionblood was rapid. Mwed very low level IHC results clearl

endent manner, as cot take up ICPC (F

estimation of R2* oncentrations of ICP

ntrast MR images oFig. 3b). IHC analysd the PB staining (Fnalysis. Titration of as selectively targete

ytate), an establishech as doxorubicin, sy of ICPC to target adeveloped a tumor-@ICPC, may potent

y 49, 10216 (2010). 1362 (1978). [8] Gu

fic Image Con

ute, Gachon Univ

ight be ideal imagintargets TAMs, and ion of TAMs [2], wnary results that stro

metry (ITC) experimxing equimolar conco the Fe3+-phytate sor i.v. injection of th) staining using an a

ch represent inflamme imaged for relax0.3 mM). After incu

% heat-inactivated Fer the control of thehe tumor was allownal LNs were harvesnnel surface coil fordifferent echo times 56×256; 1 slice (0.56, and 24 h after ior GE and 4000/58 m

f Fe3+ into phytate nother set with low

n (10 μmol⋅kg-1) inMaximal ICPC uptak

ls of ICPC uptake, aly showed that ICP

compared to unstimFig. 2b), confirming

of ICPC in vitro. TPC resulted in an r2

*

of the B16F1-GFP sis demonstrated th

Fig. 3b). f doxorubicin into pted in tumor regions

ed radiopharmaceutsubsequently forminactivated macropha-specific MRI agenttially achieve both

[4] Kuziel WA,2. Pudewicz PW, J Ce

ntrast and Dr

versity, Incheon, K

ng targets for non-ivalidated its efficac

we also developed aongly support the p

ments using a Microcentrations of Fe3+ iolution (pH = 6.0).e agent (10 μmol⋅kantibody against F4

mation-activated celxation rate (R2*) mubation for 12 h, th

FBS (Gibco, USA) e ubiquitin C promowed to grow to ~ 1.sted from the mice.r signal reception ((TEs) ranging 3.14 mm); NEX = 4. R2ntravenous (10 μmms for SE), FA = 90

exhibited Fe3+ bindaffinity (31.25 μM)

nto SD rats as welke in the mice occuras verified by PrussPC was engulfed b

mulated TEPM (Figg that ICPC is macro

The resulting R2* mof 1056.1 ± 105.9 m

melanoma mice whhat ICPC was prefer

hytate showed that s of metastatic LNs

ical agent for PET ng insoluble particleages within tumor ret for use in the accurTAM-specific MR i

PNAS 94, 12053 (19ll Biol 87, 427 (19

rug

Korea,

invasive cy in an an ICPC potential

ocal 200 ions and

g-1) into 4/80 was

lls [4]. mapping. he plates

and 1% oter. We 0 cm in

(Bruker, 4 - 10.14 2* were

mol⋅kg-1) 0º; FOV

ding site ). These

ll as its rred at 4 ian blue y tissue

. 2a). In ophage-

maps are mM-1s-1,

here the rentially

phytate s, which

[7]. The es under egions is rate and imaging

997). [5] 980). [9]

1637Proc. Intl. Soc. Mag. Reson. Med. 20 (2012)

Recommended